The data intelligence platform for life sciences

Aigenpulse - The Data Intelligence Platform for Life Sciences

Find out more



Matt Haw and Janet Burt of RSM UK Restructuring Advisory LLP were appointed Joint Administrators of the Company on 17 December 2021.

The Company has ceased to trade. Please use the following contact details if you require any further information;

Email: /

Tel – 0203 201 8000

The Joint Administrators act as agents of the Company and without personal liability.



The data intelligence platform for life sciences


The ACED2 technology framework
underpins successful scientific decision making


Maximise the value of your flow cytometry data


Aigenpulse launches unbiased analysis
features for flow cytometry


Combining machine learning and human expertise
to facilitate the efficient creation of better drugs

previous arrow
next arrow

Maximise the value of your flow cytometry data

Are your flow cytometry analyses being hampered by laborious manual gating and the vast output of highly complex data?

Now, the CytoML Suite in the Aigenpulse Platform automates and enables higher quality insights from cytometry data in research, analytical and process development, clinical development and manufacturing.

Flow cytometry data analysis is built upon the principle of gating, which is often completed manually and is a laborious process, requiring significant expertise and hands-on time.

The CytoML Suite helps users automatically gate their flow cytometry data with semi-automated gating and fully unbiased approaches. 


Where researchers need data to support a regulatory filing, guided semi-automated analysis is key because it provides significant time savings and is 100% reproducible.


Find out more about our platform

Unbiased analysis

The latest release of CytoML (v5.2) introduces new unbiased analysis features which allow complex multi-dimensional data to be simplified, unified, processed, and visualised so that it can be more easily explored.

Read more in our blog post

Spending too much time processing and analysing your flow cytometry data?
 We have a solution.

Download our whitepaper for more information

The Aigenpulse flow cytometry analysis solution enables you to:


Save time
  • Increase throughput of your flow cytometry data processing and analytics by as much as 600%.
  • Free up to 80% of scientists’ hands-on time.
  • Automate end-to-end process for large numbers of raw files by leveraging workspace templating and machine learning to empower cytometry processing and analytics.


Improve reproducibility
  • Simultaneously increase accuracy, reproducibility and quality of flow cytometry data processing and analytics.
  • High level of accuracy (equivalent to and surpassing that of manual gating) can be achieved.
  • Automated gating with CytoML is more robust to variation than manual gating.


Streamline data processing and QC
  • Integrate R&D and clinical data into one platform – supporting organisations to make data-driven decisions.
  • Data agnostic: Multi-omics, imaging, biophysical, biochemical – reduce management & resource burden.
  • Analytics and insight generation through scalable and configurable workflows, visualisations and dashboards.


Enable GxP validation
  • All CytoML processes align to GxP/GAMP5 guidelines, are ISO27001 and ISO 9001 certified, and meet US – 21 CFR Part 11 and EudraLex – Volume 4 – GMP – Annex 11 regulations.
  • Every analysis, every dataset, every parameter, every report generated in the Aigenpulse CytoML Suite is retrievable and reproducible with timestamps, user information, parameters used and data input and output.

Click below to find out how Aigenpulse can help expedite your drug discovery process.

Speak to a scientist

Client testimonials

Hear what clients have to say about our platform

  • Google Cloud
  • OBN
  • Pistoia Alliance
  • One Nucleus